- List
- By Topic
- On Map
- Search Details

Hyperinsulinism
Need help? See RSS Feeds
Choose a feed type:

Hyperinsulinism (2139 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02604485 | Completed | A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT02604485 | X358602 | October 2015 | January 2017 | January 2017 | November 13, 2015 | February 6, 2017 |
|
||
2 | NCT02524639 | Recruiting | Sirolimus for the Treatment of Hyperinsulinism |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
6 | All | up to 12 Months (Child) | NCT02524639 | 15-011973 | August 2015 | June 2018 | June 2018 | August 17, 2015 | October 17, 2017 |
|
||
3 | NCT02021604 | Recruiting | Fluorodopa F 18 in Congenital Hyperinsulinism |
|
|
Interventional | Phase 1 |
|
Other |
|
|
50 | All | up to 18 Years (Child, Adult) | NCT02021604 | 2012-060 | December 2013 | January 2019 | June 2019 | December 27, 2013 | September 1, 2017 |
|
||
4 | NCT00987168 | Completed | Sandostatine® LP and Hyperinsulinism |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
10 | All | 6 Months to 16 Years (Child) | NCT00987168 | CRC 07024 | May 2009 | April 2011 | June 2011 | September 30, 2009 | December 19, 2013 |
|
||
5 | NCT01070758 | Unknown † | Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
10 | All | 2 Years to 8 Years (Child) | NCT01070758 | SHEBA-10-7165-DM-CTIL | February 2010 | February 2015 | February 2015 | February 18, 2010 | December 13, 2012 |
|
||
6 | NCT00571324 | Completed Has Results |
Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / NIH |
|
|
9 | All | 7 Years to 60 Years (Child, Adult) | NCT00571324 | 2007-1-5131 R03DK078535-01 |
August 2007 | December 2014 | December 2014 | December 12, 2007 | December 11, 2017 | November 9, 2016 |
|
|
7 | NCT02937558 | Recruiting | CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism |
|
|
Interventional | Phase 2 |
|
Industry / NIH |
|
|
12 | All | up to 12 Months (Child) | NCT02937558 | XSGO-CH01 1R44DK105691-01 |
October 2016 | May 2018 | June 2018 | October 18, 2016 | October 17, 2017 |
|
||
8 | NCT02108730 | Completed | Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism |
|
|
Observational |
|
Other |
|
|
14 | All | Child, Adult, Senior | NCT02108730 | 123456 | non-focal CHI | March 2011 | March 2014 | March 2014 | April 9, 2014 | April 9, 2014 |
|
||
9 | NCT00004825 | Completed | Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism |
|
|
Interventional | Not Applicable |
|
U.S. Fed / Other |
|
10 | All | 1 Month to 18 Years (Child, Adult) | NCT00004825 | 199/13283 CHP-FDR001181-ST |
May 1998 | May 1998 | February 25, 2000 | March 25, 2015 | |||||
10 | NCT00004699 | Completed | Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism |
|
|
Interventional | Not Applicable |
|
Other |
|
8 | All | up to 3 Months (Child) | NCT00004699 | 199/13381 CHP-FDR001181-DR |
August 1995 | January 1999 | February 25, 2000 | March 25, 2015 | |||||
11 | NCT00004700 | Completed | Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism |
|
|
Interventional | Phase 2 |
|
Other |
|
16 | All | 3 Months to 18 Years (Child, Adult) | NCT00004700 | 199/13382 CHP-FDR001181-DBPC |
August 1995 | January 1999 | February 25, 2000 | March 25, 2015 | |||||
12 | NCT00897676 | Completed Has Results |
Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
17 | All | 6 Months to 18 Years (Child, Adult) | NCT00897676 | 2008-10-6255 R01FD004905 |
May 2009 | August 26, 2016 | January 2017 | May 12, 2009 | January 18, 2018 | January 18, 2018 |
|
|
13 | NCT00835328 | Recruiting | Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
20 | All | up to 12 Months (Child) | NCT00835328 | 2008-10-6256 | February 2009 | February 2019 | September 2019 | February 3, 2009 | March 9, 2018 |
|
||
14 | NCT00674440 | Completed | Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism |
|
|
Interventional | Phase 2 |
|
Other |
|
|
105 | All | up to 18 Years (Child, Adult) | NCT00674440 | 04-003683 FD-R-003457-01 |
December 2004 | December 2008 | February 2018 | May 7, 2008 | February 19, 2018 |
|
||
15 | NCT02835131 | Available | Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia |
|
|
Expanded Access |
|
Other | All | 18 Years to 90 Years (Adult, Senior) | NCT02835131 | 2015-5564 | July 15, 2016 | July 15, 2016 |
|
|||||||||
16 | NCT03303196 | Not yet recruiting | Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes |
|
|
Interventional | Not Applicable |
|
Other |
|
|
7 | All | 6 Years to 30 Years (Child, Adult) | NCT03303196 | 17-014144 | April 2018 | December 2018 | December 2018 | October 5, 2017 | February 13, 2018 | |||
17 | NCT00005654 | Completed | Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome |
|
|
Interventional | Not Applicable |
|
NIH / Other |
|
88 | Female | 18 Years to 40 Years (Adult) | NCT00005654 | 199/14914 UVA-WSE023 |
January 2000 | May 3, 2000 | June 24, 2005 | ||||||
18 | NCT00005104 | Completed | Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome |
|
|
Interventional | Not Applicable |
|
NIH / Other |
|
99 | Female | 18 Years to 40 Years (Adult) | NCT00005104 | 199/14915 UVA-HIC-7538 UVA-WSE026 |
January 2000 | April 7, 2000 | June 24, 2005 |
|
|||||
19 | NCT00151684 | Completed | Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men |
|
|
Interventional | Phase 2 |
|
Other |
|
|
25 | Male | 30 Years to 50 Years (Adult) | NCT00151684 | LTC-268-060504 | November 2004 | September 9, 2005 | February 29, 2008 |
|
||||
20 | NCT01819584 | Unknown † | Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism |
|
Observational |
|
Other |
|
|
30 | All | Child, Adult, Senior | NCT01819584 | SHEBA-12-9794-KM-CTIL | April 2013 | December 2014 | December 2015 | March 27, 2013 | March 27, 2013 | |||||
21 | NCT03455049 | Recruiting | The Effect of Andrographis Paniculata to GLP-1, Fasting Insulin, Insulin 2-h Post OGTT, and HOMA-IR |
|
|
Interventional | Not Applicable |
|
Other |
|
|
80 | All | 18 Years to 60 Years (Adult) | NCT03455049 | IndonesiaU-02 | October 17, 2017 | May 30, 2018 | May 30, 2018 | March 6, 2018 | April 4, 2018 |
|
||
22 | NCT00937079 | Completed | Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients |
|
|
Observational |
|
Other |
|
|
30 | All | 18 Years to 90 Years (Adult, Senior) | NCT00937079 | OCS-01778-1 | November 2007 | December 2011 | December 2011 | July 10, 2009 | January 9, 2015 |
|
|||
23 | NCT00624104 | Completed | VLDL-triglyceride Under Acute Hyperinsulinaemia |
|
|
Observational |
|
Other |
|
16 | Male | 20 Years to 65 Years (Adult) | NCT00624104 | ES-0001 | March 2008 | December 2010 | December 2010 | February 26, 2008 | November 7, 2011 |
|
||||
24 | NCT00001624 | Completed | Effect of Insulin on Endothelin-Dependent Vascular Tone in the Forearm Circulation |
|
|
Interventional | Phase 1 |
|
NIH |
|
16 | All | Child, Adult, Senior | NCT00001624 | 970100 97-H-0100 |
March 1997 | March 2000 | December 10, 2002 | March 4, 2008 |
|
||||
25 | NCT01468454 | Completed | Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia |
|
|
Interventional | Phase 2 |
|
Other |
|
|
128 | All | Child, Adult, Senior | NCT01468454 | 08-006211 | F-DOPA PET | January 2009 | June 2014 | February 2018 | November 9, 2011 | February 19, 2018 |
|
|
26 | NCT02996812 | Active, not recruiting | Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia |
|
|
Interventional | Phase 1 |
|
Other |
|
|
9 | All | 18 Years to 65 Years (Adult) | NCT02996812 | 34054 | April 2015 | May 2016 | May 2017 | December 19, 2016 | December 19, 2016 |
|
||
27 | NCT01125150 | Completed | Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia |
|
|
Observational |
|
Other |
|
9 | All | 11 Years and older (Child, Adult, Senior) | NCT01125150 | IRB5339 | February 2009 | June 2012 | June 2012 | May 18, 2010 | September 6, 2012 |
|
||||
28 | NCT03053284 | Not yet recruiting | Pasireotide in Hyperinsulinemic Hypoglycemia |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
4 | All | 18 Years to 70 Years (Adult, Senior) | NCT03053284 | 2016-7044 | April 2017 | January 2018 | April 2018 | February 15, 2017 | February 15, 2017 | |||
29 | NCT00005760 | Completed | Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 Diabetes |
|
Observational |
|
NIH | 10 | Female | Child, Adult, Senior | NCT00005760 | 000115 00-CH-0115 |
May 2000 | January 2002 | May 29, 2000 | March 4, 2008 |
|
|||||||
30 | NCT01342614 | Completed | The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension |
|
|
Interventional | Not Applicable |
|
Other |
|
|
140 | All | 20 Years to 65 Years (Adult) | NCT01342614 | MET140 | May 2006 | August 2009 | August 2009 | April 27, 2011 | May 13, 2011 | |||
31 | NCT02642523 | Withdrawn | Natriuretic Peptides and Metabolic Risk in Obesity |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
0 | All | 18 Years to 50 Years (Adult) | NCT02642523 | 151768 | February 2017 | February 2017 | December 30, 2015 | November 6, 2017 | ||||
32 | NCT00015691 | Completed | Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities |
|
|
Interventional | Not Applicable |
|
NIH |
|
105 | All | 18 Years to 65 Years (Adult) | NCT00015691 | A5082 AACTG A5082 ACTG A5082 10913 |
January 2006 | August 31, 2001 | July 22, 2013 |
|
|||||
33 | NCT02533219 | Available | Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia |
|
|
Expanded Access |
|
Other | All | up to 64 Years (Child, Adult) | NCT02533219 | H-32432 | [18F]-DOPA | August 26, 2015 | October 12, 2016 |
|
||||||||
34 | NCT01916148 | Available | 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia |
|
|
Expanded Access |
|
Other | All | Child, Adult, Senior | NCT01916148 | 12-009528 | August 5, 2013 | February 16, 2018 |
|
|||||||||
35 | NCT00618072 | Completed Has Results |
EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance |
|
|
Interventional | Phase 2 |
|
Other |
|
|
46 | Female | 35 Years to 55 Years (Adult) | NCT00618072 | GSK-109157 GSK CRN: 007674 |
EMPOWIR | January 2008 | January 2011 | January 2011 | February 18, 2008 | March 28, 2014 | March 28, 2014 |
|
36 | NCT00005669 | Completed Has Results |
Metformin to Treat Obesity in Children With Insulin Resistance |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
100 | All | 6 Years to 12 Years (Child) | NCT00005669 | 000134 00-CH-0134 |
May 2000 | August 2009 | May 2011 | May 22, 2000 | May 8, 2015 | April 7, 2011 |
|
|
37 | NCT02971202 | Recruiting | Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2) |
|
|
Interventional | Phase 1 |
|
Other |
|
|
30 | All | 13 Years to 35 Years (Child, Adult) | NCT02971202 | 161504 | December 2016 | June 2018 | June 2019 | November 22, 2016 | January 26, 2018 |
|
||
38 | NCT00279851 | Unknown † | Blood Sugars in Children With Idiopathic Seizures. |
|
Observational |
|
Other |
|
225 | All | up to 17 Years (Child) | NCT00279851 | 05046 | February 2006 | August 2007 | January 20, 2006 | September 11, 2006 |
|
||||||
39 | NCT02148250 | Completed | PK/PD STUDY OF U-500 REGULAR INSULIN |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
15 | All | 30 Years to 65 Years (Adult) | NCT02148250 | 140019 | July 2015 | December 2017 | December 2017 | May 28, 2014 | January 18, 2018 |
|
||
40 | NCT00409422 | Completed | Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children |
|
|
Interventional | Not Applicable |
|
Other |
|
|
200 | All | 8 Years to 16 Years (Child) | NCT00409422 | HIC 15994 | May 2002 | October 2006 | February 2007 | December 8, 2006 | June 24, 2008 |
|
||
41 | NCT00667498 | Completed | Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance |
|
|
Interventional | Phase 4 |
|
Other / NIH |
|
|
28 | All | 13 Years to 17 Years (Child) | NCT00667498 | 0311026134 | March 2004 | December 2007 | December 2007 | April 28, 2008 | February 18, 2009 |
|
||
42 | NCT01408667 | Completed | Hyperinsulinemic Euglycemic Clamp Protocol |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
40 | Male | 30 Years to 65 Years (Adult) | NCT01408667 | CT/P015/CMR/2010/02_01 2011-002398-42 |
November 2011 | March 2012 | August 3, 2011 | July 10, 2012 |
|
|||
43 | NCT00197132 | Completed | Study In Patients With Insulin Resistance |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
18 | All | 30 Years to 65 Years (Adult) | NCT00197132 | 49653/375 | October 2002 | August 2003 | August 2003 | September 20, 2005 | December 5, 2016 |
|
||
44 | NCT02653092 | Recruiting | Reprometabolic Syndrome Mediates Subfertility in Obesity |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | Female | 18 Years to 38 Years (Adult) | NCT02653092 | 15-1052 UL1TR001082 |
June 2016 | March 2018 | March 2019 | January 12, 2016 | August 31, 2017 |
|
||
45 | NCT02852759 | Recruiting | A Cold Physical Treatment to Manage Insulin Resistance |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years to 60 Years (Adult) | NCT02852759 | XJTU1AF-CRS-2016-018 | CTPMIR | August 2016 | July 2018 | September 2018 | August 2, 2016 | January 23, 2018 |
|
|
46 | NCT01409382 | Completed Has Results |
Maternal Lifestyle and Neonatal Hypoglycemia |
|
|
Interventional | Not Applicable |
|
Other |
|
|
480 | All | up to 40 Years (Child, Adult) | NCT01409382 | 000416-09-08-2010 | March 2011 | April 2013 | October 2015 | August 4, 2011 | September 29, 2016 | January 21, 2016 |
|
|
47 | NCT02248272 | Completed | Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes |
|
|
Interventional | Not Applicable |
|
Other |
|
|
110 | All | Child, Adult, Senior | NCT02248272 | 8062 HUA |
October 2011 | September 2013 | September 2013 | September 25, 2014 | October 4, 2017 | |||
48 | NCT01946347 | Completed | Endothelial Function in Patients With Type 2 Diabetes Versus Healthy Subjects |
|
|
Interventional | Not Applicable |
|
Other |
|
|
60 | All | 30 Years to 65 Years (Adult) | NCT01946347 | G981 | EndoPat | September 2013 | November 2015 | December 2015 | September 19, 2013 | March 7, 2016 |
|
|
49 | NCT03042416 | Recruiting | 18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety |
|
|
Interventional | Phase 3 |
|
Other |
|
|
400 | All | Child, Adult, Senior | NCT03042416 | Pro00055342 | June 29, 2017 | December 31, 2021 | December 31, 2022 | February 3, 2017 | October 26, 2017 |
|
||
50 | NCT00005709 | Completed | Lipoprotein Metabolism in Hypertensive African-Americans |
|
Observational |
|
NIH | Male | up to 100 Years (Child, Adult, Senior) | NCT00005709 | 4918 R01HL051536 |
September 1993 | August 1998 | May 26, 2000 | May 13, 2016 |
† Study has passed its completion date and status has not been verified in more than two years.